Fundraising Fox

Andrew Shaw

Founder

Founder at Attomarker Seed

Greater Exeter Area

FoundedAttomarker Seed

About

Andrew Shaw is the founder and CEO of Attomarker Ltd and an Associate Professor of Physical Chemistry. He began his career in quantum mechanics and spent two years at Stanford before founding EvanesCo in 2001, a company focused on counter-terrorism and chemical and biological weapons detection, which he later sold in 2006. Following a research grant at the University of Exeter, he developed the core technology behind Attomarker, which works on diagnostics for bacterial and viral infections and assays for COVID-19 antibody response and Long COVID classification.

Founder at Attomarker Seed

Intro paths

In turn, Andrew can intro founders to Attomarker Seed's investors below.

Experience

  1. Attomarker LtdCEO and Foundercurrent2015 — presentExeter, United Kingdom
  2. Attomarker LtdFounder and Director of Research2007 — 2015Innovation Centre, University of Exeter
  3. University of ExeterAssociate Professor of Physical Chemistrycurrent2001 — present
  4. ArkirisChairman2009 — 2012Innovation Centre, University of Exeter
  5. EvanesCo LtdFounder and Director of Research2002 — 2009

Skills & more

EntrepreneurshipBoard of Directors5Biotechnology15Technology Transfer22Healthcare Information Technology3Medical Diagnostics4Guest Lecturing4Public Lectures4Biomarkers3Biochemistry8Chemistry6Data Analysis5
+9 moreLecturingLifesciencesMolecular BiologyPhysical ChemistryScientific WritingResearchSurface Plasmon ResonanceAntibodiesDiagnostic

From Andrew's professional profile.

Frequently asked questions

Who is Andrew Shaw?
Andrew Shaw is the founder and CEO of Attomarker Ltd and an Associate Professor of Physical Chemistry. He began his career in quantum mechanics and spent two years at Stanford before founding EvanesCo in 2001, a company focused on counter-terrorism and chemical and biological weapons detection, which he later sold in 2006. Following a research grant at the University of Exeter, he developed the core technology behind Attomarker, which works on diagnostics for bacterial and viral infections and assays for COVID-19 antibody response and Long COVID classification.
Where does Andrew Shaw work?
Andrew Shaw is Founder of Attomarker Seed.
What companies did Andrew Shaw found?
Andrew Shaw founded Attomarker Seed.
Where did Andrew Shaw go to school?
Andrew Shaw studied at University of Cambridge (MA, Natural Sciences); University of Southampton (PhD, Gas Phase Physical Chemistry); Stanford University (Post Doctoral Scientist, Physical Chemistry).

Founder mafias

Same school

Shared employers